Your browser doesn't support javascript.
loading
Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
Oh, Yumin; Park, Ogyi; Swierczewska, Magdalena; Hamilton, James P; Park, Jong-Sung; Kim, Tae Hyung; Lim, Sung-Mook; Eom, Hana; Jo, Dong Gyu; Lee, Choong-Eun; Kechrid, Raouf; Mastorakos, Panagiotis; Zhang, Clark; Hahn, Sei Kwang; Jeon, Ok-Cheol; Byun, Youngro; Kim, Kwangmeyung; Hanes, Justin; Lee, Kang Choon; Pomper, Martin G; Gao, Bin; Lee, Seulki.
  • Oh Y; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Park O; The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Swierczewska M; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Hamilton JP; The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Park JS; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD.
  • Kim TH; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Lim SM; The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Eom H; Divison of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Jo DG; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Lee CE; The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Kechrid R; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Mastorakos P; The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Zhang C; College of Pharmacy, Sungkyunkwan University, Suwon, Korea.
  • Hahn SK; College of Pharmacy, Sungkyunkwan University, Suwon, Korea.
  • Jeon OC; College of Pharmacy, Sungkyunkwan University, Suwon, Korea.
  • Byun Y; Department of Biological Science, Sungkyunkwan University, Suwon, Korea.
  • Kim K; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD.
  • Hanes J; The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Lee KC; The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Pomper MG; Department of Materials Science and Engineering, Pohang University of Science and Technology, Pohang, Korea.
  • Gao B; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Lee S; College of Pharmacy, Seoul National University, Seoul, Korea.
Hepatology ; 64(1): 209-23, 2016 07.
Article en En | MEDLINE | ID: mdl-26710118
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ligando Inductor de Apoptosis Relacionado con TNF / Células Estrelladas Hepáticas / Cirrosis Hepática Límite: Animals / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ligando Inductor de Apoptosis Relacionado con TNF / Células Estrelladas Hepáticas / Cirrosis Hepática Límite: Animals / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article